相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer
Shinkichi Takamori et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Short- and long-term survival outcomes among never smokers who developed lung cancer
Barbara Nemesure et al.
CANCER EPIDEMIOLOGY (2021)
Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer
Jianyuan Zhang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
K. Park et al.
ANNALS OF ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy
Olarn Roengvoraphoj et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Predicting EGFR mutation subtypes in lung adenocarcinoma using F-18-FDG PET/CT radiomic features
Qiufang Liu et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Non-invasive decision support for NSCLC treatment using PET/CT radiomics
Wei Mu et al.
NATURE COMMUNICATIONS (2020)
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
Y. -L. Wu et al.
ANNALS OF ONCOLOGY (2019)
Value of 18F-FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients
Zhilei Lv et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
Andrew G. Nicholson et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Metabolic Phenotype of Stage IV Lung Adenocarcinoma Relationship With Epidermal Growth Factor Receptor Mutation
Elaine Yuen Phin Lee et al.
CLINICAL NUCLEAR MEDICINE (2015)
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
Antonio Nappi et al.
RADIOLOGY AND ONCOLOGY (2015)
Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non-Small-Cell Lung Cancer Receiving Radiotherapy Meta-Analysis
Feifei Na et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapy
Seung Hwan Moon et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
Marianne Paesmans et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Gender, Histology, and Time of Diagnosis Are Important Factors for Prognosis Analysis of 1499 Never-Smokers with Advanced Non-small Cell Lung Cancer in Japan
Tomoya Kawaguchi et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer A Comprehensive Analysis of 26,957 Patients with NSCLC
Tomoya Kawaguchi et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment
Masaru Jida et al.
CANCER SCIENCE (2009)
Never-smoking nonsmall cell lung cancer as a separate entity - Clinicopathologic features and survival
Tokujiro Yano et al.
CANCER (2008)
18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer
Im Il Na et al.
CLINICAL CANCER RESEARCH (2008)
Molecular genetics of lung cancer in people who have never smoked
Janakiraman Subramanian et al.
LANCET ONCOLOGY (2008)
Lung cancer in never smokers - a different disease
Sophie Sun et al.
NATURE REVIEWS CANCER (2007)
The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer
Shuji Ichihara et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Epidemiology of lung cancer - ACCP evidence-based clinical practice guidelines (2nd edition)
Anthony J. Alberg et al.
CHEST (2007)
Never-smokers with lung cancer: Epidemiologic evidence of a distinct disease entity
Chee-Keong Toh et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas
DK Pham et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
H Shigematsu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung
LT Nordquist et al.
CHEST (2004)
Mutations of the epidermal growth factor receptor gene in lung cancer:: Biological and clinical implications
T Kosaka et al.
CANCER RESEARCH (2004)
分享论文
